Drug
Doxapram
Doxapram is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
40%
Ph not_applicable
1
20%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Other(1)
Detailed Status
Recruiting2
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)
Trials by Status
recruiting240%
unknown120%
completed240%
Recent Activity
2 active trials
Showing 5 of 5
recruiting
Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial
NCT07022704
recruitingphase_3
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT04430790
completedphase_4
Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants
NCT00389909
unknownnot_applicable
The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence
NCT02820025
completedphase_4
Doxapram as an Additive to Propofol Sedation in Sedation for ERCP
NCT02171910
Clinical Trials (5)
Showing 5 of 5 trials
NCT07022704
Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial
NCT04430790Phase 3
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT00389909Phase 4
Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants
NCT02820025Not Applicable
The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence
NCT02171910Phase 4
Doxapram as an Additive to Propofol Sedation in Sedation for ERCP
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5